Pregabalin
Contents
Description
Pregabalin is a structural analogue of GABA that binds to voltage-gated calcium channels, reducing neurotransmitter release. It is effective for neuropathic pain management in hereditary motor neuropathies including Charcot-Marie-Tooth disease variants. The medication can significantly reduce pain intensity and improve functional outcomes in affected patients.
Indications & Therapeutic Use
neuropathic pain, diabetic peripheral neuropathy, fibromyalgia, partial seizures
Global Availability (10 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Pregabalin — GNH India
676 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | pregabalin |
| Brands | 1 brand available |
| Active Ingredient | pregabalin |
| Drug Class | neuropathic pain |
| Manufacturer | Pfizer |
| Dosage Forms | oral capsule 25mg, 50mg, 75mg, 100mg, 150mg, 200mg, 225mg, 300mg; oral solution 20mg/mL |
| Medical Code | N03AX16 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 5 days |
| Reg. Status | FDA Approved |
| Countries | 10 countries |